Sentences with phrase «vaccine manufacturers said»

At a high - level meeting at WHO, vaccine manufacturers said they might be able to produce more vaccine earlier than they thought

Not exact matches

Manufacturer Says Some Lots of H1N1 Lost Potency None of the H1N1 vaccine involved in a voluntary manufacturer's recall due to a loss of potency had been shipped to the Oneida County Health Department, County Executive Anthony J. Picente, Jr. and health department officials confManufacturer Says Some Lots of H1N1 Lost Potency None of the H1N1 vaccine involved in a voluntary manufacturer's recall due to a loss of potency had been shipped to the Oneida County Health Department, County Executive Anthony J. Picente, Jr. and health department officials confmanufacturer's recall due to a loss of potency had been shipped to the Oneida County Health Department, County Executive Anthony J. Picente, Jr. and health department officials confirmed today.
Some Vaccine in Latest Recall Administered by Oneida County Health Department «Potency of Nasal Spray Vaccine in Question — Safety Not an Issue» The Oneida County Health Department's current supply of H1N1 flu vaccine will not be affected by the latest voluntary manufacturer's recall of the product, Daniel W. Gilmore, Acting Director of the departmenVaccine in Latest Recall Administered by Oneida County Health Department «Potency of Nasal Spray Vaccine in Question — Safety Not an Issue» The Oneida County Health Department's current supply of H1N1 flu vaccine will not be affected by the latest voluntary manufacturer's recall of the product, Daniel W. Gilmore, Acting Director of the departmenVaccine in Question — Safety Not an Issue» The Oneida County Health Department's current supply of H1N1 flu vaccine will not be affected by the latest voluntary manufacturer's recall of the product, Daniel W. Gilmore, Acting Director of the departmenvaccine will not be affected by the latest voluntary manufacturer's recall of the product, Daniel W. Gilmore, Acting Director of the department said.
No Recalled Vaccine Shipped to Oneida County Health Manufacturer Says Some Lots of H1N1 Lost Potency None of the H1N1 vaccine involved in a voluntary manufacturer's recall due to a loss of potency had been shipped to the Oneida County Health Department, County Executive Anthony J. Picente, Jr. and health department officials confirmedVaccine Shipped to Oneida County Health Manufacturer Says Some Lots of H1N1 Lost Potency None of the H1N1 vaccine involved in a voluntary manufacturer's recall due to a loss of potency had been shipped to the Oneida County Health Department, County Executive Anthony J. Picente, Jr. and health department officials confManufacturer Says Some Lots of H1N1 Lost Potency None of the H1N1 vaccine involved in a voluntary manufacturer's recall due to a loss of potency had been shipped to the Oneida County Health Department, County Executive Anthony J. Picente, Jr. and health department officials confirmedvaccine involved in a voluntary manufacturer's recall due to a loss of potency had been shipped to the Oneida County Health Department, County Executive Anthony J. Picente, Jr. and health department officials confmanufacturer's recall due to a loss of potency had been shipped to the Oneida County Health Department, County Executive Anthony J. Picente, Jr. and health department officials confirmed today.
The shortage also has become an issue on the campaign trail, with Democratic candidate Sen. John Kerry blaming the Bush administration for not paying attention to warning signs about possible shortages and the Bush campaign inferring that vaccine manufacturers are hindered by fears of lawsuits, something the campaign said Kerry would not move to fix.
The manufacturer of the sole dengue vaccine on the market says a new study shows that it should only be used in people who have had a previous infection from the mosquito - borne virus.
«The issue is not influenza vaccines in general, but one manufacturer's vaccine in one year,» he says.
One of the Lyon - based investors is vaccine manufacturer Sanofi Pasteur, whose president, Jacques Berger, sees many benefits to the changes: «There's no rivalry between those who want to work in state - funded research and those who want to work in the private sector,» he says.
At this point, the U.S. government expects manufacturers to deliver 45 million to 52 million doses of the vaccine by mid-October, said Jay Butler, head of the H1N1 task force for the U.S. Centers for Disease Control and Prevention.
They say that opening companies up to lawsuits «could drive vaccine manufacturers from the market and halt the future production and development of childhood vaccines in this country.»
Supporters of the AMC concept say that it addresses an immediate problem by providing a reason for manufacturers to provide pneumococcal vaccines to needy populations.
Unlike other medical treatments for which companies are driven to keep their products safe because of liability threats, their brief says «the Vaccine Program itself provides no incentive to vaccine manufacturers to make their vaccines safer.Vaccine Program itself provides no incentive to vaccine manufacturers to make their vaccines safer.vaccine manufacturers to make their vaccines safer.»
Nearly 80 million people in 77 countries received the influenza vaccine with WHO's help — including providing a «seed» strain of the virus used by manufacturers — but the report says that «numerous systemic difficulties» slowed distribution to low - resource countries.
Frieden, who called the delays «enormously frustrating,» said manufacturers have difficulty growing the viruses used to make vaccine.
Vaccine manufacturers have notified officials that they can't make good on their targets, Anne Schuchat, director of CDC's National Center for Immunization and Respiratory Diseases, said during a press conference today.
«Such a system would address barriers to vaccine manufacturers» participation as well as individual perceptions that fuel vaccine hesitancy in low - resource counties,» Halabi said.
In a dissenting opinion, they accused the court of imposing «its own bare policy preferences» to protect vaccine manufacturers and said it was important for companies to be pushed, at times by litigation, to improve on existing vaccines.
«Because viruses typically mutate during vaccine production, manufacturers have to screen for mutations, and decide which ones can be tolerated and which ones can't,» Heaton said.
Several companies and federal agencies have already contacted him about the influenza A and influenza B backbones, Kawaoka says, and he is hopeful the systems can be adopted by vaccine manufacturers and grown in cell culture facilities already available in the United States and Japan.
Sanjay Gurunathan from Sanofi Pasteur, manufacturer of one of the vaccines used in RV144, said a new partnership of the US National Institute of Allergy and Infectious Diseases, The Bill & Melinda Gates Foundation, HIV Vaccine Trials Network, US Military HIV Research Program (MHRP), and Sanofi Pasteur — known as the Pox Protein Public Private Partnership, or P5 — will aim to increase vaccine efficacy from the 31.2 percent of the RV144 trial to 50 pVaccine Trials Network, US Military HIV Research Program (MHRP), and Sanofi Pasteur — known as the Pox Protein Public Private Partnership, or P5 — will aim to increase vaccine efficacy from the 31.2 percent of the RV144 trial to 50 pvaccine efficacy from the 31.2 percent of the RV144 trial to 50 percent.
Merck, itself a multinational vaccine manufacturer, states in The Merck Manual of Diagnosis and Therapy that autoimmune haemolytic anaemia may be caused by modified live - virus vaccines, as do Tizard's Veterinary Immunology (4th edition) and the Journal of Veterinary Internal Medicine.6 The British Government's Working Group, despite being staffed by vaccine - industry consultants who say they are independent, also acknowledged this fact.
Dodds says that after 20 years of following the United States Department of Agriculture and the drug manufacturer's recommendations to make annual vaccines a standard in veterinary care, professionals who first challenged the standard school of thought were considered rebels.
Cecil Metzger, a spokesman for Norden Laboratories in Lincoln, Neb., one of the nation's largest manufacturers of rabies vaccines, said his company and others don't make blanket recommendations for annual inoculations.
«While the vaccines may have a three - year duration, the manufacturers still recommend annual shots,» said Xan Rawls, Brevard County animal control director.
One American veterinary vaccine manufacturer has made a public announcement, saying that it no longer recommends annual vaccination.
a b c d e f g h i j k l m n o p q r s t u v w x y z